KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) Shares Outstanding (Diluted Average) (2016 - 2025)

Vertex Pharmaceuticals has reported Shares Outstanding (Diluted Average) over the past 17 years, most recently at $258.0 million for Q4 2025.

  • Quarterly results put Shares Outstanding (Diluted Average) at $258.0 million for Q4 2025, changed 0.04% from a year ago — trailing twelve months through Dec 2025 was $258.0 million (changed 0.04% YoY), and the annual figure for FY2025 was $258.0 million, changed 0.04%.
  • Shares Outstanding (Diluted Average) for Q4 2025 was $258.0 million at Vertex Pharmaceuticals, roughly flat from $258.6 million in the prior quarter.
  • Over the last five years, Shares Outstanding (Diluted Average) for VRTX hit a ceiling of $261.9 million in Q1 2021 and a floor of $257.9 million in Q1 2022.
  • Median Shares Outstanding (Diluted Average) over the past 5 years was $259.7 million (2021), compared with a mean of $259.7 million.
  • Biggest five-year swings in Shares Outstanding (Diluted Average): dropped 1.53% in 2022 and later grew 0.93% in 2023.
  • Vertex Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $259.9 million in 2021, then fell by 0.31% to $259.1 million in 2022, then rose by 0.54% to $260.5 million in 2023, then decreased by 1.0% to $257.9 million in 2024, then grew by 0.04% to $258.0 million in 2025.
  • The last three reported values for Shares Outstanding (Diluted Average) were $258.0 million (Q4 2025), $258.6 million (Q3 2025), and $259.2 million (Q2 2025) per Business Quant data.